A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir

NCT07577986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV (Human Immunodeficiency Virus)

Interventions

DRUG: Chidamide Combined with NKG2D CAR-NK Cell Therapy

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]